Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody

✍ Scribed by Takahiro Maeda; Yasuaki Yamada; Masayuki Tawara; Reishi Yamasaki; Yuichi Yakata; Chizuko Tsutsumi; Yasuyuki Onimaru; Simeru Kamihira; Masao Tomonaga

• Publisher: Carden Jennings Publishing
• Year: 2001
• Tongue: English
• Weight: 188 KB
• Volume: 74
• Category: Article
• ISSN: 0925-5710
• DOI: 10.1007/bf02982552